ASCL1 and prostate adenocarcinoma: A decrease in immune infiltration was also observed in NEPC regions of a prostatectomy specimen from a patient with mixed PRAD/NEPC histology, with CD11c+;CD68+ TAMs present within ASCL1+ tumor areas (Extended Data Fig. 6i,j).